Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesDisease-modifying treatment in systemic sclerosis: current status
Current Opinion in Rheumatology, 09/18/09
Quillinan NP et al. – A number of novel agents including antiinterleukin–6, transforming growth factor–[beta]–directed therapies and other novel biological agents such as hyperimmune caprine serum are being developed based on new insights into the pathophysiology of disease.
Related Articles
Systemic Sclerosis: Environmental Factors
Journal of Rheumatology, 10/06/09
Relevance Score: 80%
Malnutrition is common in systemic sclerosis: results from the Canadian Scleroderma Research Group database
Journal of Rheumatology, 10/19/09
Relevance Score: 79%
What is the relationship between disease activity, severity and damage in a large Canadian systemic sclerosis cohort - Results from the Canadian Scleroderma Research Group (CSRG)
Rheumatology International, 10/02/09
Relevance Score: 79%
Systemic sclerosis as a model of chronic rejection in facial composite tissue transplantation
Journal of Plastic, Reconstructive & Aesthetic Surgery, 10/06/09
Relevance Score: 78%
Measures of Response in Clinical Trials of Systemic Sclerosis: The Combined Response Index for Systemic Sclerosis (CRISS) and Outcome Measures in Pulmonary Arterial Hypertension Related to Systemic Sclerosis (EPOSS)
Journal of Rheumatology, 10/15/09
Relevance Score: 72%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
A prospective phase II study of cetuximab in combination with XELOX (capecitabine and oxaliplatin) in patients with metastatic and/or recurrent advanced gastric cancer
Investigational New Drugs, 12/17/09
ACC, AHA Update Guidelines for Beta Blockers
American Family Physician, 12/17/09
Pharmacist and physician collaborative prescribing: For medication renewals within a primary health centre
Canadian Family Physician, 12/17/09
Today in Rheumatology...keeping you current
Receive free subspecialty "5-minute updates" via email
Taking the stress out of managing gout
Canadian Family Physician, 12/17/09
Phytalgic(R), a food supplement, vs placebo in patients with osteoarthritis of the knee or hip: a randomised double-blind placebo-controlled clinical trial
Arthritis Research & Therapy, 12/17/09
Elevated Circulating and Synovial Fluid Endoglin Are Associated with Primary Knee Osteoarthritis Severity
Archives of Medical Research, 12/17/09
Sponsor
Article Search
Sponsor
Sponsor